Hôpital Jean-Minjoz
Besançon 25030
1 studies enrolling now · 12 studies all time
What they study most
Acute Leukemia (Category), Alcoholic Hepatitis (AH), Breast Cancer Metastatic, Cardiovascular Diseases, Colorectal Cancer Metastatic, Diabetes Mellitus, Type 2, Gastrointestinal Stromal Tumors, Hypertension, Intracerebral Hemorrhage, Metastatic Breast Cancer, Pancreatic Cancer, Psoriasis
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- EO4010 in Previously Treated Metastatic Colorectal Carcinoma — Stopped early
- Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer — Completed
- A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed
- MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer. — Completed
- Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) — Stopped early
- Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia — Stopped early
- Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH) — Completed
- Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients — Completed
- Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer — Completed
- A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis — Stopped early
- The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial — Completed